NCCN Guidelines® Insights - Survivorship, Version 1.2023
These NCCN Guidelines Insights summarize recent guideline updates and panel discussions pertaining to sleep disorders, fatigue, and cognitive function in cancer survivors.
Category
- Survivorship
Format
- Monograph/Journal Supplement
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Advances in the Management of Metastatic Breast Cancer with SABCS Updates
With expanding treatment options, clinicians are challenged to understand important criteria used in selecting optimal first- and subsequent-line therapies for individuals with metastatic breast cancer. Staying up-to-date with the available treatment options is important to integrate new evidence-based data into their clinical practice, and being familiar with their toxicity profiles is important to optimize patient outcomes.
Category
- Breast Cancer
Format
- Recorded Webcast
Credits
- 1.25 AAPA Category 1 CME credit
- 1.25 ACPE contact hours
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC contact hours
- 1.25 Participation
Archived Monthly Oncology Tumor Boards: Treatment of Deficient Mismatch Repair or Microsatellite Instability-High (dMMR/MSI-H) Colorectal Cancer
As the clinical understanding of biomarkers in colorectal cancer has deepened, it has become increasingly clear that deficient mismatch repair or microsatellite instability-high (dMMR/MSI-H) colorectal cancer should be treated differently from proficient mismatch repair or microsatellite stable (pMMR/MSS) disease in order to reach the best possible outcomes for patients.
Category
- Colorectal Cancer
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
Acute Myeloid Leukemia: Reviewing Current Best Practice and Exploring Novel Paradigms Ahead
The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with AML.
Category
- Acute Myelogenous Leukemia
Format
- Recorded Webcast
Credits
- 2.00 AAPA Category 1 CME credit
- 2.00 ACPE contact hours
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC contact hours
- 2.00 Participation
Application of the Latest Data in CLL/SLL: Guidance for Current and Future Treatment Strategies
The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with CLL/SLL.
Category
- Chronic Lymphocytic Leukemia
Format
- Recorded Webcast
Credits
- 2.00 AAPA Category 1 CME credit
- 2.00 ACPE contact hours
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC contact hours
- 2.00 Participation
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations
The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with CLL/SLL.
Category
- Chronic Lymphocytic Leukemia
Format
- Recorded Webcast
Credits
- 1.75 AAPA Category 1 CME credit
- 1.75 ACPE contact hours
- 1.75 AMA PRA Category 1 Credit™
- 1.75 ANCC contact hours
- 1.75 Participation
Evidence-Based Guidance on New Paradigms in the Treatment of Acute Myeloid Leukemia
The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with AML.Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
Category
- Acute Myelogenous Leukemia
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Prostate Cancer in Black Individuals: How Can We Do Better?
The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of prostate cancer in Black patients.
Category
- Prostate Cancer
Format
- Enduring Activity
Credits
- 0.50 AAPA Category 1 CME credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC contact hours
- 0.50 Participation
Diagnosis and Management of Breast Cancer: What does the Evidence Show, What are We Doing, And What’s on the Horizon?
The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast cancer in Black patients.
Category
- Breast Cancer
Format
- Enduring Activity
Credits
- 0.75 AAPA Category 1 CME credit
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC contact hours
- 0.75 Participation
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors
The goal of this initiative is to provide education to assist clinicians in providing appropriate care for patients with non-small cell lung cancer (NSCLC) through a greater understanding of the significance of biomarker testing to predict treatment response, the role of PD-1/PD-L1 inhibitors in
Category
- Lung Cancers
Format
- Recorded Webcast
Credits
- 1.75 AAPA Category 1 CME credit
- 1.75 AMA PRA Category 1 Credit™
- 1.75 ANCC contact hours
- 1.75 Participation